RecruitingNot ApplicableNCT06283004

Investigation of Walking Training With Different Slope Types in COPD Patients

The Effect of Aerobic Exercise Training in Different Slope Types on Exercise Capacity, Respiratory Functions, Muscle Strength, and Functional Status in COPD Patients

Sponsor

Acibadem University

Enrollment

51 participants

Start Date

Apr 9, 2025

Study Type

INTERVENTIONAL

Conditions

Pulmonary Disease, Chronic Obstructive

Summary

Chronic obstructive pulmonary disease (COPD) is a disease that continues to generate a great deal of research and this research must continue, both because it is not completely curable and because of the large patient population. The importance and benefits of exercise training in COPD patients are clear. One of the most preferred types of exercise training is the so-called aerobic exercise training, which typically takes the form of walking. A typical walking training does not use a slope or may include an uphill slope. However, recently there have been publications about downhill walking and its benefits in COPD. Walking on a level, uphill, and downhill slope may have the potential to result in different gains by using different muscle groups more. Therefore, this study aimed to compare the effects of walking training on exercise capacity, respiratory functions, muscle strength, and functional status in COPD patients with three different slope types: level, uphill, and downhill.

Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing different types of treadmill walking training — flat, uphill, and downhill — in people with COPD (chronic obstructive pulmonary disease, a chronic lung condition). The goal is to find out which type of incline walking is most beneficial for improving exercise capacity and quality of life. **You may be eligible if...** - You have been diagnosed with COPD (classified as group A, B, or E by GOLD guidelines) - You can walk independently - You do not have any medical condition preventing exercise - You have adequate cognitive function (score 24 or above on a mental status test) **You may NOT be eligible if...** - Your COPD is very severe (GOLD spirometric stage 4) - You have low oxygen levels (hypoxemia) - You participated in a pulmonary rehabilitation program in the last 6 months - You had a COPD flare-up (exacerbation) in the last month - You have another lung condition (asthma, bronchiectasis) - You have a heart, bone, or nerve condition that affects your ability to exercise safely Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERDownhill walking training

For 8 weeks, downhill walking training will be done 2 times a week at a slope of -10 degrees.

OTHERLevel walking training

For 8 weeks, level walking training will be done 2 times a week at a slope of 0 degrees.

OTHERUphill walking training

For 8 weeks, uphill walking training will be done 2 times a week at a slope of +10 degrees.

Locations(1)

Bezmialem Vakif University, Department of Physiotherapy and Rehabilitation

Istanbul, Eyüp Sultan, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06283004

Related Trials

Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting

NCT067125637 locations

Monitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD Exacerbations

NCT057048812 locations

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

NCT06961214159 locations

Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD

NCT057181025 locations

Trial to Determine Effective Aspirin Dose in COPD

NCT052652991 location